GEMCITABINE-DOCETAXEL VERSUS CISPLATIN-GEMCITABINE AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Al-Gizawy, S. M. [1 ]
Mostafa, H. G. [1 ]
机构：
[1] Assiut Univ, Dept Clin Oncol, Fac Med, Assiut, Egypt
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/j.ejca.2014.03.065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P0021
引用
收藏
页码：E15 / E15
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis Of EGFR Mutation Testing And Afatinib Versus Gemcitabine-Cisplatin As First-Line Therapy For Advanced Non-Small-Cell Lung Cancer In China
    You, Ruxu
    Liu, Jinyu
    Wu, David Bin-Chia
    Qian, XinYu
    Lyu, Boxiang
    Zhang, Yu
    Luo, Nan
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10239 - 10248
  • [42] First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly 'unfrail' patients with advanced non-small-cell lung cancer: a multicenter phase II study
    Tibaldi, C.
    Camerini, A.
    D'Incecco, A.
    Vasile, E.
    Fabbri, A.
    Amoroso, D.
    Cappuzzo, F.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (12) : 2003 - 2008
  • [43] First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly ‘unfrail’ patients with advanced non-small-cell lung cancer: a multicenter phase II study
    C. Tibaldi
    A. Camerini
    A. D’Incecco
    E. Vasile
    A. Fabbri
    D. Amoroso
    F. Cappuzzo
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 2003 - 2008
  • [44] A COMPARISON OF FIRST-LINE TREATMENT WITH GEMCITABINE PLUS DOCETAXEL VERSUS GEMCITABINE PLUS VINORELBINE IN WOMEN WITH METASTATIC BREAST CANCER
    Bensalem, A.
    Bouzid, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [45] Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer:A phase II open-label clinical study
    Shanshan Qin
    Hui Yu
    Xianghua Wu
    Zhiguo Luo
    Huijie Wang
    Si Sun
    Mingzhu Huang
    Jia Jin
    Zhonghua Tao
    Jie Qiao
    Yu Feng
    Jialei Wang
    Jianhua Chang
    Chinese Journal of Cancer Research, 2019, 31 (02) : 339 - 348
  • [46] Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study
    Qin, Shanshan
    Yu, Hui
    Wu, Xianghua
    Luo, Zhiguo
    Wang, Huijie
    Sun, Si
    Huang, Mingzhu
    Jin, Jia
    Tao, Zhonghua
    Qiao, Jie
    Feng, Yu
    Wang, Jialei
    Chang, Jianhua
    CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (02) : 339 - 348
  • [47] Gemcitabine and cisplatin as a first line therapy in non-small cell lung cancer: Preliminary Czech experience
    Pesek, M
    Eliasova, B
    Certikova, G
    ANNALS OF ONCOLOGY, 1998, 9 : 96 - 97
  • [48] Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Neubauer, MA
    Garfield, DH
    Kuerfler, PR
    Raju, RN
    Lindquist, DL
    Soo, EW
    Khan, M
    Boehm, KA
    Asmar, L
    LUNG CANCER, 2005, 47 (01) : 121 - 127
  • [49] An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
    Chang, John Wen-Cheng
    Thongprasert, Sumitra
    Wright, Elaine
    Tsang, Kenneth
    Kim, Heung Tae
    Ahn, Myung-Ju
    Kim, Joo-Hang
    Kang, Jin Hyoung
    Kim, Sang-We
    Walzer, Stefan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 : 13 - 21
  • [50] COST EFFECTIVENESS OF ERLOTINIB VERSUS GEMCITABINE/CARBOPLATIN IN FIRST-LINE THERAPY OF ADVANCED EGFR-MUTATIONS POSITIVE NON-SMALL-CELL LUNG CANCER
    Hoang, B.
    Nguyen, T.
    VALUE IN HEALTH, 2016, 19 (03) : A152 - A152
12345